Immunitybio (IBRX)Director sold ~$851K

~$851K

Approx. value · 81K sh @ $10.50

100K

Holds after · shares reported

Traded

Oct 2, 2026

Filed

Oct 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
2. Sep 28, 2026CongressDisclosed purchase of IBRX — reported range $1,001 - $15,000
3. Sep 30, 2026CongressDisclosed purchase of IBRX — reported range $1,001 - $15,000
4. Oct 2, 2026 · this disclosureInsiderDirector sold ~$851K of IBRX shares in the open market

What came next

1. Oct 5, 2026InsiderDirector sold ~$269K of IBRX shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Immunitybio

For Immunitybio, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 2 Congress trade reports dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IBRX page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Immunitybio

• House Clerk periodic transaction reportOct 12, 2026
• House Clerk periodic transaction reportOct 12, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 144Oct 5, 2026
• SEC Form 144Oct 2, 2026
• House Clerk periodic transaction reportApr 17, 2023

Everything OQRO holds on this company is on its IBRX page.